Related content

Response to Comments by Seaman et al. on “Analysis of Longitudinal Trials With Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” Journal of Biopharmaceutical Statistics 23:1352–1371

By        

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1363-1369

Taylor & Francis Ltd

Access to resources Recommend Favorite

Defining, Evaluating, and Removing Bias Induced by Linear Imputation in Longitudinal Clinical Trials with MNAR Missing Data

By Helms Ronald  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 226-251

Taylor & Francis Ltd

Access to resources Recommend Favorite

Estimating the Effect of Multiple Imputation on Incomplete Longitudinal Data with Application to a Randomized Clinical Study

By Fong Daniel Y. T.   Rai Shesh N.   Lam Karen S. L.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1004-1022

Taylor & Francis Ltd

Access to resources Recommend Favorite

Comparison of Several Multiple Imputation Strategies for Repeated Measures Analysis of Clinical Scales: To Truncate or Not To?

By          

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 924-943

Taylor & Francis Ltd

Access to resources Recommend Favorite

Multiple Imputation under the Generalized Lambda Distribution

By Demirtas Hakan  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 1, 2009-01 ,pp. : 77-89

Taylor & Francis Ltd

Access to resources Recommend Favorite